Dr. Patricia Cristine Dugan, MD

Dr. Dugan practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Dugan's NPI, 1467789107, was assigned on November 16, 2009. Dr. Dugan graduated from University of the East College of Medicine in 2002. Dr. Dugan holds New York license 249029.

Dr. Dugan's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Dugan's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Dugan is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Dugan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dugan practices, 2 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Dugan's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Dugan is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Dugan is licensed in New York.

Dmand AI lists epilepsy, head injury and vertigo among the conditions Dr. Dugan treats.

CMS data shows 253 Medicare services from Dr. Dugan across 6 procedure codes in 2024, for 151 Medicare patients. Medicare paid $22,974 for them.

CMS counts 151 Medicare patients who saw Dr. Dugan in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dugan's median patient age at 37, with 55% women.

In 2024, Dr. Dugan wrote 1,210 Medicare Part D claims for 129 patients. 70% of them were for generic drugs. CMS names the drug for 1,097 of them, across 30 drugs with 11 or more claims each, at $705,997 in total drug cost. In 2023, CMS named 1,189 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dugan for performance year 2024, reported as part of a group. Dr. Dugan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dugan as offering telehealth.

Dmand AI links 100 papers to Dr. Dugan, published from 2012 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Epilepsy, Electroencephalography and Electrocorticography. Dr. Dugan has published most often in bioRxiv. Dr. Dugan's most frequent co-authors are Orrin Devinsky, MD, Werner K. Doyle, MD and Daniel B. Friedman, MD.

CMS Open Payments shows 147 general payments to Dr. Dugan from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 85% of the total. Neuropace, Inc. paid the most, $107,434. It also lists 481 research payments totaling $225,105 from 2016 to 2025.

Dmand AI lists 1 award for Dr. Dugan, most recently CMS Stage 1 EHR in 2013.

Dr. Dugan graduated from University of the East College of Medicine in 2002.

Dr. Dugan is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.